Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 219

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Functional genomics of PCOS: from GWAS to molecular mechanisms

Open access
McAllister, Jan M., Legro, Richard S., Modi, Bhavi P., Strauss, Jerome F. · 2015 · Trends in Endocrinology & Metabolism

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrinopathy characterized by increased ovarian androgen biosynthesis, anovulation, and infertility. PCOS has a strong heritable component based on familial clustering and twin studies. Genome-wide association studies (GWAS) identified several PCOS candidate loci including, DENND1A, LHCGR, FSHR, ZNF217, YAP1, INSR, RAB5B, and C9orf3. Here, we review the functional roles of strong PCOS candidate loci focusing on FSHR, LHCGR, INSR and DENND1A. We propose that these candidates comprise a hierarchical signaling network by which DENND1A, LHCGR, INSR, RAB5B, adapter proteins, and associated downstream signaling cascades converge to regulate theca cell androgen biosynthesis. Future elucidation of the functional gene networks predicted by the PCOS GWAS will result in new diagnostic and therapeutic approaches for women with PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tem.2014.12.004

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 75

  1. De Leo, 2010, Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome, Contraception, 82, 276, 10.1016/j.contraception.2010.04.002 · DOI
  2. Azziz, 2003, Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome, Fertil. Steril., 79, 932, 10.1016/S0015-0282(02)04914-2 · DOI
  3. Azziz, 2001, Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial, J. Clin. Endocrinol. Metab., 86, 1626
  4. Gilling-Smith, 1994, Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries, J. Clin. Endocrinol. Metab., 79, 1158
  5. Nelson, 1999, Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries, Mol. Endocrinol., 13, 946, 10.1210/mend.13.6.0311 · DOI · Paper page
  6. Wickenheisser, 2000, Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells, J. Clin. Endocrinol. Metab., 85, 2304
  7. Magoffin, 2006, Ovarian enzyme activities in women with polycystic ovary syndrome, Fertil. Steril., 86, S9, 10.1016/j.fertnstert.2006.03.015 · DOI
  8. Jakimiuk, 2001, Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries, J. Clin. Endocrinol. Metab., 86, 1318
  9. Wickenheisser, 2005, Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 90, 1720, 10.1210/jc.2004-1860 · DOI
  10. Wickenheisser, 2004, Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1, Mol. Endocrinol., 18, 588, 10.1210/me.2003-0090 · DOI
  11. Wood, 2004, The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling, J. Reprod. Immunol., 63, 51, 10.1016/j.jri.2004.01.010 · DOI
  12. Wood, 2003, The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis, J. Biol. Chem., 278, 26380, 10.1074/jbc.M300688200 · DOI · Paper page
  13. Ho, 2005, Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells, J. Clin. Endocrinol. Metab., 90, 6596, 10.1210/jc.2005-0890 · DOI
  14. Legro, 1998, Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome, Proc. Natl. Acad. Sci. U.S.A., 95, 14956, 10.1073/pnas.95.25.14956 · DOI · Paper page
  15. Strauss, 2012, Persistence pays off for PCOS gene prospectors, J. Clin. Endocrinol. Metab., 97, 2286, 10.1210/jc.2012-2109 · DOI
  16. Goodarzi, 2012, Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts, J. Med. Genet., 49, 90, 10.1136/jmedgenet-2011-100427 · DOI · Paper page
  17. Welt, 2012, Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry, J. Clin. Endocrinol. Metab., 97, E1342, 10.1210/jc.2011-3478 · DOI · Paper page
  18. Eriksen, 2013, Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS), PLoS ONE, 8, e77186, 10.1371/journal.pone.0077186 · DOI
  19. Louwers, 2013, Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 98, E2006, 10.1210/jc.2013-2495 · DOI
  20. Franks, 1999, Insulin action in the normal and polycystic ovary, Endocrinol. Metab. Clin. North Am., 28, 361, 10.1016/S0889-8529(05)70074-8 · DOI · Paper page
  21. Unsal, 2009, Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome, J. Assist. Reprod. Genet., 26, 205, 10.1007/s10815-009-9308-8 · DOI
  22. Dolfin, 2011, FSH-receptor Ala307Thr polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women, J. Assist. Reprod. Genet., 28, 925, 10.1007/s10815-011-9619-4 · DOI
  23. Fu, 2013, Association study between FSHR Ala307Thr and Ser680Asn variants and polycystic ovary syndrome (PCOS) in Northern Chinese Han women, J. Assist. Reprod. Genet., 30, 717, 10.1007/s10815-013-9979-z · DOI
  24. Ioannidis, 2010, Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis, Mol. Genet. Metab., 99, 174, 10.1016/j.ymgme.2009.10.013 · DOI
  25. Talbot, 1996, Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome, J. Clin. Endocrinol. Metab., 81, 1979
  26. Mutharasan, 2013, Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry, J. Clin. Endocrinol. Metab., 98, E185, 10.1210/jc.2012-2471 · DOI
  27. Gu, 2010, Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome, Int. J. Mol. Med., 26, 107
  28. Wu, 2014, Association between FSHR polymorphisms and polycystic ovary syndrome among Chinese women in north China, J. Assist. Reprod. Genet., 31, 371, 10.1007/s10815-013-0166-z · DOI
  29. Aittomaki, 1995, Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure, Cell, 82, 959, 10.1016/0092-8674(95)90275-9 · DOI · Paper page
  30. Huhtaniemi, 2000, The Parkes lecture. Mutations of gonadotrophin and gonadotrophin receptor genes: what do they teach us about reproductive physiology?, J. Reprod. Fertil., 119, 173, 10.1530/reprod/119.2.173 · doi:10.1530/reprod/119.2.173
  31. Du, 2010, Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome, Mol. Genet. Metab., 100, 292, 10.1016/j.ymgme.2010.03.018 · DOI
  32. Conway, 1999, Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome, Clin. Endocrinol., 51, 97, 10.1046/j.1365-2265.1999.00745.x · DOI
  33. Overbeek, 2009, Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome, Hum. Reprod., 24, 2007, 10.1093/humrep/dep114 · DOI
  34. Sudo, 2002, Genetic and functional analyses of polymorphisms in the human FSH receptor gene, Mol. Hum. Reprod., 8, 893, 10.1093/molehr/8.10.893 · DOI · Paper page
  35. Simoni, 2002, Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction, Hum. Reprod. Update, 8, 413, 10.1093/humupd/8.5.413 · DOI · Paper page
  36. Toledo, 1996, An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46, XX female, J. Clin. Endocrinol. Metab., 81, 3850
  37. Liu, 2012, Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome, Reprod. Biol. Endocrinol., 10, 36, 10.1186/1477-7827-10-36 · DOI
  38. Latronico, 2000, The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary–gonadal axis in both sexes, Clin. Endocrinol., 53, 609, 10.1046/j.1365-2265.2000.01135.x · DOI
  39. Piersma, 2007, LH receptor gene mutations and polymorphisms: an overview, Mol. Cell. Endocrinol., 260–262, 282, 10.1016/j.mce.2005.11.048 · DOI
  40. Capalbo, 2012, The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2.7-fold increased risk of polycystic ovary syndrome in a Sardinian population, Clin. Endocrinol., 77, 113, 10.1111/j.1365-2265.2012.04372.x · DOI
  41. Rager, 2006, Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN, Sci. World J., 6, 116, 10.1100/tsw.2006.23 · DOI
  42. Globerman, 1998, Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance), Int. J. Obes. Relat. Metab. Disord., 22, 349, 10.1038/sj.ijo.0800593 · DOI
  43. Urbanek, 1999, Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin, Proc. Natl. Acad. Sci. U.S.A., 96, 8573, 10.1073/pnas.96.15.8573 · DOI · Paper page
  44. Villuendas, 2003, Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome, Fertil. Steril., 79, 219, 10.1016/S0015-0282(02)04570-3 · DOI
  45. Tucci, 2001, Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus, J. Clin. Endocrinol. Metab., 86, 446, 10.1210/jcem.86.1.7274 · DOI
  46. Stewart, 2006, Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity, J. Clin. Endocrinol. Metab., 91, 4112, 10.1210/jc.2006-0951 · DOI
  47. Ewens, 2010, Family-based analysis of candidate genes for polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 95, 2306, 10.1210/jc.2009-2703 · DOI
  48. Xie, 2013, Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: a case–control study and meta-analysis, Reprod. Biomed. Online, 26, 168, 10.1016/j.rbmo.2012.10.014 · DOI
  49. Lee, 2006, Single nucleotide polymorphism in exon 17 of the insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population, Fertil. Steril., 86, 380, 10.1016/j.fertnstert.2005.12.073 · DOI
  50. Chen, 2004, Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome, Chin. J. Obstet. Gynecol., 39, 582
  51. Jin, 2006, A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS, Mol. Hum. Reprod., 12, 151, 10.1093/molehr/gal022 · DOI
  52. Mukherjee, 2009, Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome, Eur. J. Endocrinol., 160, 855, 10.1530/EJE-08-0932 · DOI
  53. Ramezani Tehrani, 2013, Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS, Iran. J. Reprod. Med., 11, 185
  54. Lee, 2008, A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome, Fertil. Steril., 89, 1213, 10.1016/j.fertnstert.2007.05.026 · DOI
  55. Xu, 2011, Family association study between INSR gene polymorphisms and PCOS in Han Chinese, Reprod. Biol. Endocrinol., 9, 76, 10.1186/1477-7827-9-76 · DOI
  56. Goodarzi, 2011, Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome, Fertil. Steril., 95, 1736, 10.1016/j.fertnstert.2011.01.015 · DOI
  57. Hanzu, 2010, Association of insulin receptor genetic variants with polycystic ovary syndrome in a population of women from Central Europe, Fertil. Steril., 94, 2389, 10.1016/j.fertnstert.2010.04.029 · doi:10.1016/j.fertnstert.2010.04.029
  58. Marat, 2011, DENN domain proteins: regulators of Rab GTPases, J. Biol. Chem., 286, 13791, 10.1074/jbc.R110.217067 · DOI · Paper page
  59. Legro, 2002, Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 87, 2134, 10.1210/jcem.87.5.8387 · doi:10.1210/jcem.87.5.8387 · Paper page
  60. Ehrmann, 1995, Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion, Endocr. Rev., 16, 322, 10.1210/er.16.3.322 · DOI · Paper page
  61. Yildiz, 2007, The adrenal and polycystic ovary syndrome, Rev. Endocr. Metab. Disord., 8, 331, 10.1007/s11154-007-9054-0 · DOI
  62. Cui, 2013, Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women, Hum. Reprod., 28, 538, 10.1093/humrep/des424 · DOI
  63. Wang, 2012, Variants in DENND1A and LHCGR are associated with endometrioid adenocarcinoma, Gynecol. Oncol., 2, 403, 10.1016/j.ygyno.2012.08.007 · DOI
  64. Allaire, 2010, The Connecdenn DENN domain: a GEF for Rab35 mediating cargo-specific exit from early endosomes, Mol. Cell, 37, 370, 10.1016/j.molcel.2009.12.037 · DOI · Paper page
  65. Cowger, 2007, Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence, Oncogene, 26, 3378, 10.1038/sj.onc.1210126 · DOI
  66. Yuan, 2009, TOX3 regulates calcium-dependent transcription in neurons, Proc. Natl. Acad. Sci. U.S.A., 106, 2909, 10.1073/pnas.0805555106 · DOI
  67. Munir, 2004, Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells, Endocrinology, 145, 175, 10.1210/en.2003-0329 · DOI · Paper page
  68. Zhang, 2012, Activation and significance of the PI3K/Akt pathway in endometrium with polycystic ovary syndrome patients, Zhonghua fu chan ke za zhi, 47, 19
  69. Ciaraldi, 2000, Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity, J. Pediatr. Endocrinol. Metab., 13, 1291
  70. Hojlund, 2008, Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment, Diabetes, 57, 357, 10.2337/db07-0706 · DOI
  71. Dunaif, 2013, Renaming PCOS – a two-state solution, J. Clin. Endocrinol. Metab., 98, 4325, 10.1210/jc.2013-2040 · DOI
  72. National Institutes of Health (2012) Evidence-Based Methodology Workshop for Polycystic Ovarian Syndrome December 3–5, 2012, https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf
  73. Marat, 2012, Connecdenn 3/DENND1C binds actin linking Rab35 activation to the actin cytoskeleton, Mol. Biol. Cell, 23, 163, 10.1091/mbc.E11-05-0474 · DOI
  74. Stenmark, 2001, The Rab GTPase family, Genome Biol., 2, 10.1186/gb-2001-2-5-reviews3007 · DOI
  75. Noro, 2003, Molecular dissection of the architectural transcription factor HMGA2, Biochemistry, 42, 4569, 10.1021/bi026605k · DOI

Cited by

See all 219

Metadata

Authors
McAllister, J. M., Legro, R. S., Modi, B. P., & Strauss, J. F.
Venue
Trends in Endocrinology & Metabolism
Publisher
Elsevier BV
Published
2015-03
Volume
26
Issue
3
Pages
118-124
ISSN
1043-2760 (ISSN-L)
OpenAlex
W1984125311
Cited by
219
References
13
FWCI
3.44
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.